Detection of reduced orexin-A/hypocretin-1 and its fragments by orexin-A “gold-standard” radioimmunoassay
Open Access
- 10 April 2025
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 131, 106505
Abstract
No abstract availableKeywords
Funding Information
- Helsingin Yliopisto
- Itä-Suomen Yliopisto
- Finska Läkaresällskapet
This publication has 46 references indexed in Scilit:
- Exploring the role of Orexin-A neuropeptide in Parkinson's disease: A systematic review and meta-analysisClinical Neurology and Neurosurgery, 2024
- Reduced Numbers of Corticotropin‐Releasing Hormone Neurons in Narcolepsy Type 1Annals of Neurology, 2022
- Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysisSleep Medicine, 2021
- Development of a LC-ESI-MRM method for the absolute quantification of orexin A in the CSF of individual miceMedicine in Drug Discovery, 2021
- Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassaysClinical Biochemistry, 2021
- Cerebrospinal fluid dynamics at the lumbosacral level in patients with spinal stenosis: A pilot studyJournal of Orthopaedic Research, 2016
- Cysteine/cystine redox signaling in cardiovascular diseaseFree Radical Biology and Medicine, 2011
- Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medicationNeurobiology of Disease, 2004
- Widespread Distribution of Orexin in Rat Brain and Its Regulation upon FastingBiochemical and Biophysical Research Communications, 1999
- Proteinases in human cerebrospinal fluidJournal of the Neurological Sciences, 1968